Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2021-03-15
2022-04-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Automatic Gas-Controlled Low-Flow Anesthesia on Anesthetic Agent Consumption in Elective Surgeries
NCT06735937
Does Low Flow Anesthesia Reduce Postanaesthetic Emergence Agitation?
NCT03862391
The Affecting Factors on Airway Temperature and Moisture
NCT04204746
Assessment of Oxygenation With Oxygen Reserve Index for General Anesthesia
NCT04698863
Effects of Different Flow Anesthesia on Atelectasis
NCT05381701
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group AGC
The FLOW-i anesthesia machine (Maquet, Solna, Sweden) can be equipped with automated gas control (AGC), an automated low flow tool with target control of the inspired oxygen concentration (FIO2) and end-expired concentration (FA) of a potent inhaled anesthetic. İnitially before induction, we set the minimal fresh gas flow to 0.5 L min-1 and target end-expired agent concentration for 1 MAC (minimal alveolar concentration). Shortly after intubation of the patient, we switched to AGC mode.
AGC mode
Automated Gas Control mode at Maquet FLOW-i anesthesia machine
Group Minimal Flow
İn this group; following intubation, we set the fresh gas flow to 4 L min-1 and than we readjusted fresh gas flow manually to 0.5 L min-1 after sevoflurane concentration reaching to 1 MAC.
No interventions assigned to this group
Group Medium Flow
İn this group; following intubation, we set the fresh gas flow to 4 L min-1 and than we readjusted fresh gas flow manually to 2 L min-1 after sevoflurane concentration reaching to 1 MAC.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AGC mode
Automated Gas Control mode at Maquet FLOW-i anesthesia machine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergoing breast surgery
* ASA physical status I-II
* female
* operation lasting at least 1 hour
* those who agreed to volunteer for the study with an informed consent form
Exclusion Criteria
* pregnancy or breastfeeding women
* decompensated diabetes mellitus
* kidney or liver failure
* chronic obstructive pulmonary disease
* opioid sensitivity
* history of malignant hyperthermia
* history of smoking
* alcohol or drug addiction
* significant anemia
* sepsis
* BMI \>35
* patients with allergies to the drugs used in the study
18 Years
65 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zonguldak Bulent Ecevit University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gökhan Çeviker
Anesthesiologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zonguldak Bülent Ecevit University Medicine Faculty
Zonguldak, Kozlu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021/05-12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.